𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibition of 1,25-Dihydroxyvitamin D3-Dependent Transcription by Synthetic LXXLL Peptide Antagonists that Target the Activation Domains of the Vitamin D and Retinoid X Receptors

✍ Scribed by Peterson Pathrose; Olga Barmina; Ching-Yi Chang; Donald P. McDonnell; Nirupama K. Shevde; J. Wesley Pike

Book ID
111487073
Publisher
American Society for Bone and Mineral Research
Year
2002
Tongue
English
Weight
666 KB
Volume
17
Category
Article
ISSN
0884-0431

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Integration of the NfκB p65 subunit into
Integration of the NfκB p65 subunit into the vitamin D receptor transcriptional complex: Identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription
✍ Xianghuai Lu; Paul Farmer; Janet Rubin; Mark S. Nanes 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB

## Abstract Resistance to the action of vitamin D (D) occurs in response to tumor necrosis factor‐α (TNF‐α), an effect mediated by nuclear factor kappa B (NfκB). To determine the mechanism of NfκB inhibition of D‐stimulated transcription, chromatin immunoprecipitation assays (CHIP) were done in ost

Crystallization and preliminary X-ray an
Crystallization and preliminary X-ray analysis of a domain in the Runx2 transcription factor that interacts with the 1α,25 dihydroxy vitamin D3 receptor
✍ Carola Bruna; Gloria Arriagada; Jane B. Lian; Gary S. Stein; Marta Bunster; Jose 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

## Abstract The Runx2 transcription factor is a key regulator of osteoblast differentiation. In response to 1α,25 dihydroxy vitamin D3, Runx2 may interact with the 1α,25 dihydroxy vitamin D3 receptor (VDR) in the promoter of target genes, producing a synergic activation of their transcription. Prev